Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$8,334,820
+$1,125,462 QoQ
Shares Held
33,122
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#1,016
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gladstone Institutional Advisory LLC holds $67,973,516 across 11 Drug Manufacturers - General names. ABBV ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
19,736 | $23,671,952 | |
| 2 | JNJ |
Johnson & Johnson
|
52,767 | $13,401,234 | |
| 3 | MRK |
Merck & Co., Inc.
|
84,891 | $10,908,493 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
33,122 | $8,334,820 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,905 | $3,912,686 | |
| 6 | AMGN |
Amgen Inc
|
6,692 | $2,423,307 | |
| 7 | PFE |
Pfizer Inc
|
78,104 | $1,880,744 | |
| 8 | NVS |
Novartis AG
|
8,936 | $1,400,449 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,334,820 | 33,122 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $7,209,358 | 33,148 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,069,252 | 30,939 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,183,760 | 31,026 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,726,933 | 30,853 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,189,011 | 29,539 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,927,443 | 27,729 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,474,738 | 27,723 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $4,811,307 | 28,051 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,696,359 | 25,790 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,465,594 | 22,363 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,135,924 | 21,038 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,625,483 | 19,487 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,621,842 | 22,726 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,871,529 | 23,956 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $3,774,656 | 28,125 | Shares | Sole | 2023-01-30 | |
| 2022-06-30 | $5,776,123 | 37,713 | Shares | Sole | 2023-01-30 | |
| 2022-03-31 | $7,532,603 | 46,466 | Shares | Sole | 2023-01-30 | |
| 2021-12-31 | $2,934,659 | 21,674 | Shares | Sole | 2023-01-30 | |
| 2021-09-30 | $1,670,259 | 15,484 | Shares | Sole | 2023-01-30 | |
| 2021-06-30 | $1,835,694 | 16,297 | Shares | Sole | 2023-01-30 | |
| 2021-03-31 | $1,265,524 | 11,694 | Shares | Sole | 2023-01-30 | |
| 2020-12-31 | $845,306 | 7,889 | Shares | Sole | 2023-01-30 | |
| 2020-09-30 | $749,857 | 8,561 | Shares | Sole | 2023-01-30 | |
| 2020-06-30 | $1,684,474 | 17,157 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $897,746 | 11,783 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||